drugset / Trial / NCT04991194

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

NCT04991194

Phase 1 Terminated 61 enrolled Bial - Portela C S.A.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

the purpose of this study is to determine the effect of age on the Pharmacokinetics (PK) profile of BIA 5-1058 at steady state after multiple oral doses

Timeline

Start
2015-10-12
Primary completion
2016-12-30
Completion
2016-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject zamicastat Small molecule 400 mg Oral
Subject zamicastat Small molecule 1200 mg Oral